AR057508A1 - Composicion farmaceutica sinergistica de tramadol y clonixinato de lisina - Google Patents
Composicion farmaceutica sinergistica de tramadol y clonixinato de lisinaInfo
- Publication number
- AR057508A1 AR057508A1 ARP070101074A ARP070101074A AR057508A1 AR 057508 A1 AR057508 A1 AR 057508A1 AR P070101074 A ARP070101074 A AR P070101074A AR P070101074 A ARP070101074 A AR P070101074A AR 057508 A1 AR057508 A1 AR 057508A1
- Authority
- AR
- Argentina
- Prior art keywords
- tramadol
- clonixinate
- analgesia
- drugs
- lisine
- Prior art date
Links
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 title abstract 2
- 229960004380 tramadol Drugs 0.000 title abstract 2
- TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 title abstract 2
- 230000002195 synergetic effect Effects 0.000 title 1
- 229940079593 drug Drugs 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- 230000036592 analgesia Effects 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 206010010774 Constipation Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 abstract 1
- 206010038678 Respiratory depression Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 208000005298 acute pain Diseases 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- CVNFYQCHAWFYQI-ZSCHJXSPSA-N clonixin lysine salt Chemical compound NCCCC[C@H](N)C(O)=O.CC1=C(Cl)C=CC=C1NC1=NC=CC=C1C(O)=O CVNFYQCHAWFYQI-ZSCHJXSPSA-N 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 229960003763 lysine clonixinate Drugs 0.000 abstract 1
- 239000000014 opioid analgesic Substances 0.000 abstract 1
- 229940005483 opioid analgesics Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000003637 steroidlike Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/MX2006/000018 WO2007105929A1 (fr) | 2006-03-16 | 2006-03-16 | Composition pharmaceutique synergique à base de tramadol et de clonixinate de lysine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR057508A1 true AR057508A1 (es) | 2007-12-05 |
Family
ID=38509710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070101074A AR057508A1 (es) | 2006-03-16 | 2007-03-16 | Composicion farmaceutica sinergistica de tramadol y clonixinato de lisina |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR057508A1 (fr) |
| WO (1) | WO2007105929A1 (fr) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU661723B2 (en) * | 1991-10-30 | 1995-08-03 | Mcneilab, Inc. | Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
-
2006
- 2006-03-16 WO PCT/MX2006/000018 patent/WO2007105929A1/fr not_active Ceased
-
2007
- 2007-03-16 AR ARP070101074A patent/AR057508A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007105929A1 (fr) | 2007-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001082914A3 (fr) | Formulations topiques a base d'anesthesique et d'opioide, et utilisations associees | |
| WO2007112274A3 (fr) | Formulations de médicaments anti-inflammatoires non stéroïdiens à faible dose et bêta-cyclodextrine | |
| WO2007143155A3 (fr) | Forme pharmaceutique à liberation prolongée contenant de la phényléphrine | |
| ZA200810125B (en) | Pharmaceutical combination comprising 3- (3-dimethy-lamin0-1-ethyl-2-methyl-pr0pyl)-phenol and an NSAID | |
| WO2008064192A3 (fr) | Suspensions analgésiques à libération modifiée | |
| DE602007002154D1 (de) | Analgesische Zusammensetzung von topisch angewendeten, nichtsteroiden und entzündungshemmenden Arzneimitteln und Opioiden | |
| AR040038A1 (es) | Composicion analgesica que comprende un agonista alfa-adrenergico con una actividad agonista alfa-2a minima y uso de un agonista alfa-adrenergico y un antagonista selectivo alfa-2a para preparar composiciones farmaceuticas para aliviar el dolor | |
| AR082167A1 (es) | Formas de dosificacion gastrorretentivas | |
| BRPI0415953B8 (pt) | formulação de dosagem de liberação controlada e conjunto de formas de dosagem de liberação controlada | |
| WO2005035485A3 (fr) | Composes analgesiques, leur synthese, et compositions pharmaceutiques les contenant | |
| ECSP099348A (es) | Composición farmacéutica de liberación modificada de un músculo relajante y un aine | |
| NZ591408A (en) | Paracetamol and Calcium carbonate composition | |
| UA87841C2 (ru) | Композиция, которая содержит амброксол, для местного применения | |
| BRPI0509245A (pt) | cloridrato [4-(5-aminoetil-2-flúor-fenil)-piperidina-1-il](4-bromo-3 -metil-5-propóxi-tiofeno-2-il)-metanona como um inibidor de triptase de mastócito | |
| AR033390A1 (es) | Una composicion farmaceutica que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina, el uso de dicha composicion para la fabricacion de un medicamento y un kit de partes | |
| DE60219963D1 (de) | Pharmazeutische zusammensetzung zur kontrolle des blutzuckers bei patienten mit typ 2 diabetes | |
| WO2006050002A3 (fr) | Compositions destinees a l'administration controlee de composes pharmaceutiquement actifs | |
| WO2005123192A3 (fr) | Procede ameliorant le traitement medical de la douleur | |
| AR065917A1 (es) | Composicion farmaceutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor | |
| AR057508A1 (es) | Composicion farmaceutica sinergistica de tramadol y clonixinato de lisina | |
| DOP2010000265A (es) | Formulacion galenica oral que comprende ketorolaco y vitaminas del complejo b, en la que la vitamina b6 se encuentra em una capa externa separada del resto de principios activos | |
| BR112021016795A8 (pt) | Administração de inibidor de enzima de ativação de sumo e inibidores de checkpoint | |
| MX2009008813A (es) | Composicion farmaceutica que contiene floroglucinol y paracetamol. | |
| CO6331430A2 (es) | Composicion farmaceutica que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b para el tratamiento de la neuralgia | |
| PE20160038A1 (es) | Composicion farmaceutica sinergistica de dos analgesicos con distinto perfil farmacocinetico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |